Login

21 CFR 1271.370 : Food And Drugs (§ 1.1 To Parts 1403-1499) — (Subpart A To Parts 1272-1299) — Food And Drug Administration, Department Of Health And Human Services (Continued) (Subpart A To Parts 1272-1299) — Regulations Under Certain Other Acts Administered By The Food And Drug Administration (§ 1210.1 To Parts 1272-1299) — Human Cells, Tissues, And Cellular And Tissue-Based Products (§ 1271.1 To § 1271.440) — Additional Requirements For Establishments Described In § 1271.10 (§ 1271.330 To § 1271.370) — Labeling.

4 Aug 2016
Link to an amendment published at 81 FR 40518, June 22, 2016.

The following requirements apply in addition to §§ 1271.55, 1271.60, 1271.65, and 1271.90:

(a) You must label each HCT/P made available for distribution clearly and accurately.

(b) The following information must appear on the HCT/P label:

(1) Distinct identification code affixed to the HCT/P container, and assigned in accordance with § 1271.290(c);

(2) Description of the type of HCT/P;

(3) Expiration date, if any; and

(4) Warnings required under § 1271.60(d)(2), § 1271.65(b)(2), or § 1271.90(b), if applicable and physically possible. If it is not physically possible to include these warnings on the label, the warnings must, instead, accompany the HCT/P.

(c) The following information must either appear on the HCT/P label or accompany the HCT/P:

(1) Name and address of the establishment that determines that the HCT/P meets release criteria and makes the HCT/P available for distribution;

(2) Storage temperature;

(3) Other warnings, where appropriate; and

(4) Instructions for use when related to the prevention of the introduction, transmission, or spread of communicable diseases.

21 CFR 1271.370
[69 FR 68686, Nov. 24, 2004, as amended at 70 FR 29952, May 25, 2005]